Literature DB >> 2764015

Physician self referral arrangements: legitimate business or unethical "entrepreneurialism".

T N McDowell1.   

Abstract

An emerging legal and ethical controversy in the health care industry centers on physician investment in health care facilities to which they make patient referrals. This Article analyzes the policy debate surrounding these physician self referral arrangements as well as the various responses to such arrangements. The Article asserts that an effective legal or ethical response to self referral arrangements must acknowledge and balance both the possible pro-competitive effects of such arrangements and the inherent potential for abuses in this type of business practice. From this perspective, the most effective form of regulation consists of extensive structural guidelines which focus on the physician's referral behavior and limit restrictions on investment procedures. Such an approach would minimize referral abuses and conflict of interest concerns but promote business and competitive freedom.

Entities:  

Keywords:  American Medical Association; Federal Trade Commission; Health Care and Public Health; Legal Approach; Medicare Fraud and Abuse Statute; Medicare and Medicaid Patient and Program Protection Act 1987

Mesh:

Year:  1989        PMID: 2764015

Source DB:  PubMed          Journal:  Am J Law Med        ISSN: 0098-8588


  4 in total

1.  Regulating self-referrals and other physician conflicts of interest.

Authors:  Nancy J Moore
Journal:  HEC Forum       Date:  2003-06

Review 2.  Physician entrepreneurs, self-referral, and conflicts of interest: an overview.

Authors:  David M Zientek
Journal:  HEC Forum       Date:  2003-06

3.  ASNC 2009 plenary session II: the federal government and cardiac imaging.

Authors:  Kim A Williams
Journal:  J Nucl Cardiol       Date:  2010-06       Impact factor: 5.952

4.  Utilization trends and positive biopsy rates for prostate biopsies in the United States: 2005 to 2011.

Authors:  Deepak A Kapoor; David G Bostwick; Savvas E Mendrinos; Ann E Anderson; Carl A Olsson
Journal:  Rev Urol       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.